Pulse Biosciences CS (PLSE) Stock Price, Quote & News

Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment c...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 510 906 4600

Website: www.pulsebiosciences.com

Address:

601 Brickell Key Drive, Suite 1080, Miami, United States

prismmarketview Jun. 30 at 3:50 PM

Better men's health begins with partners in care. This Men's Health Month, PRISM MarketView is highlighting the companies whose innovation is extending lifespans across the lifespan — from mental health to cardiovascular care to oncology. Mental Health & Access: Late-stage psychiatric therapeutics from $DFTX + DTC men's wellness scale via $HIMS Cardiovascular Innovation: Inflammatory heart disease pipeline at $CRDL + nanosecond pulsed field ablation for AF at $PLSE Precision Oncology: First-in-class EpCAM ADC for colorectal cancer from $CTMX Read our full analysis: https://prismmarketview.com/partners-in-care-how-modern-medicine-is-closing-the-gap-on-mens-health/ #MensHealthMonth #MentalHealth #Cardiology #Oncology #MarketInsights #PRISMMarketView

0 · Reply

Carl81 Jun. 29 at 4:17 PM

$PLSE $SMMT You all ready for this ?

0 · Reply

Orbit100 Jun. 29 at 2:34 PM

$PLSE Pulse is the best momentum stock to buy now.

0 · Reply

TruthBroker2 Jun. 29 at 11:56 AM

$PLSE $SMMT .

0 · Reply

TruthBroker2 Jun. 27 at 1:10 AM

$PLSE

0 · Reply

Orbit100 Jun. 26 at 7:52 PM

$PLSE I kept adding today after I bought my shares back. This time I am holding out to see this company to be bought out.

0 · Reply

Orbit100 Jun. 26 at 3:00 PM

$PLSE This time my son told me to hold it out the rest of the year. I know Pulse has the best PFA catheter in the market right now. To some point, the company definitely will be bought out.

0 · Reply

Orbit100 Jun. 26 at 2:58 PM

$PLSE What a gift! Sold $31 and bought back 15000 shares at $28.60.

0 · Reply

Orbit100 Jun. 26 at 2:28 PM

$PLSE Too much, too soon. Sold. This is a stock that I will continue trading in the next 2 years. Good luck to all of the longs.

1 · Reply

TruthBroker2 Jun. 26 at 2:16 PM

$PLSE Whats Really Going on 31

0 · Reply

Pulse Biosciences Transcript: AGM 2026

Jun 10, 2026, 10:00 AM EDT - 21 days ago

Pulse Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

2026-06-10T11:11:17.000Z - 21 days ago

Pulse Biosciences announces planned redemption of warrants

Jun 10, 2026, 7:00 AM EDT - 21 days ago

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

2026-06-04T10:46:18.000Z - 27 days ago

Canaccord starts Pulse Biosciences with Buy on ablation potential

2026-06-04T10:26:01.000Z - 27 days ago

Pulse Biosciences initiated with a Buy at Canaccord

May 27, 2026, 4:05 PM EDT - 4 weeks ago

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

May 13, 2026, 7:35 PM EDT - 6 weeks ago

Pulse Biosciences Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Pulse Biosciences Slides: Corporate presentation

2026-05-12T12:29:42.000Z - 7 weeks ago

Pulse Biosciences announces ATM equity purchases by co-chairmen

May 12, 2026, 7:00 AM EDT - 7 weeks ago

ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million

May 11, 2026, 8:00 AM EDT - 7 weeks ago

Pulse Biosciences Proxy statement: Proxy filing

May 8, 2026, 7:00 AM EDT - 7 weeks ago

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Pulse Biosciences Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Pulse Biosciences Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Pulse Biosciences Quarterly report: Q1 2026

2026-05-04T11:10:11.000Z - 2 months ago

Pulse Biosciences reports Q1 EPS (27c) vs (25c) last year

May 4, 2026, 7:00 AM EDT - 2 months ago

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

2026-04-26T17:40:28.000Z - 2 months ago

Pulse Biosciences presents clinical data from nPulse Cardiac Catheter System

Apr 25, 2026, 1:00 PM EDT - 2 months ago

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

2026-04-20T12:09:41.000Z - 2 months ago

Pulse Biosciences to feature nPulse tech at Heart Rhythm Society meeting

Apr 20, 2026, 7:00 AM EDT - 2 months ago

Pulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting

Apr 17, 2026, 7:00 AM EDT - 2 months ago

Pulse Biosciences to Host Analyst Event on April 25, 2026

Apr 16, 2026, 9:30 AM EDT - 2 months ago

Pulse Biosciences Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 16, 2026, 7:00 AM EDT - 2 months ago

Pulse Biosciences Slides: Corporate presentation

2026-04-09T11:44:40.000Z - 2 months ago

Pulse Biosciences appoints Teplitsky as Chief Operating Officer

Apr 9, 2026, 7:00 AM EDT - 2 months ago

Pulse Biosciences Strengthens Executive Leadership Team

2026-04-07T11:27:19.000Z - 3 months ago

Pulse Biosciences enrolls first patients in NANOPULSE-AF study

Apr 7, 2026, 7:00 AM EDT - 3 months ago

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

Apr 2, 2026, 4:05 PM EDT - 3 months ago

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 18, 2026, 10:40 AM EDT - 3 months ago

Pulse Biosciences Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

2026-03-17T11:21:11.000Z - 3 months ago

Pulse to accelerate development of nPulse Cardiac Catheter Ablarton System

Mar 17, 2026, 7:00 AM EDT - 3 months ago

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

Mar 12, 2026, 7:00 AM EDT - 3 months ago

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

2026-03-09T11:10:46.000Z - 4 months ago

Pulse Biosciences announces data from nPulse Vybrance study

Mar 9, 2026, 7:00 AM EDT - 4 months ago

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

Mar 5, 2026, 7:00 AM EST - 4 months ago

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 4, 2026, 1:10 PM EST - 4 months ago

Pulse Biosciences Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 7:00 AM EST - 4 months ago

Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

Mar 3, 2026, 6:00 AM EST - 4 months ago

Pulse Biosciences Slides: Corporate presentation

Feb 20, 2026, 4:05 PM EST - 4 months ago

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-02-20T13:10:48.000Z - 4 months ago

Pulse Biosciences price target raised to $30 from $22 at Oppenheimer

Feb 20, 2026, 7:00 AM EST - 4 months ago

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

Feb 19, 2026, 4:30 PM EST - 4 months ago

Pulse Biosciences Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:30 PM EST - 4 months ago

Pulse Biosciences Earnings release: Q4 2025

Feb 19, 2026, 4:30 PM EST - 4 months ago

Pulse Biosciences Annual report: Q4 2025

Feb 19, 2026, 4:05 PM EST - 4 months ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

Feb 19, 2026, 7:00 AM EST - 4 months ago

Pulse Biosciences Registration statement: Registration Filing

2026-02-06T12:41:58.000Z - 5 months ago

Pulse Biosciences price target raised to $30 from $25 at Mizuho

Feb 6, 2026, 7:00 AM EST - 5 months ago

Pulse Biosciences Press release: FY 2026

Feb 6, 2026, 7:00 AM EST - 5 months ago

Pulse Biosciences Slides: FY 2026

2026-02-06T00:10:32.000Z - 5 months ago

Pulse Biosciences says nPulse study demonstrates successful treatment

Feb 5, 2026, 7:00 PM EST - 5 months ago

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Feb 4, 2026, 4:05 PM EST - 5 months ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

Feb 3, 2026, 7:00 AM EST - 5 months ago

Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

2026-01-30T10:15:20.000Z - 5 months ago

Pulse Biosciences initiated with an Outperform at Mizuho

Jan 14, 2026, 6:45 PM EST - 5 months ago

Pulse Biosciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 5 months ago

Pulse Biosciences Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 7:00 AM EST - 6 months ago

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Jan 6, 2026, 7:00 AM EST - 6 months ago

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Dec 29, 2025, 4:05 PM EST - 6 months ago

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

2025-12-18T12:05:34.000Z - 6 months ago

Pulse Biosciences announces FDA approval of nPulse IDE

Dec 18, 2025, 7:00 AM EST - 6 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

2025-12-09T12:16:21.000Z - 7 months ago

Pulse Biosciences initiates research collaboration for thyroid cancers treatment

Dec 9, 2025, 7:00 AM EST - 7 months ago

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

Dec 3, 2025, 9:50 AM EST - 7 months ago

Pulse Biosciences Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 2:40 PM EST - 8 months ago

Pulse Biosciences Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 6:00 PM EST - 8 months ago

Pulse Biosciences Slides: Corporate Presentation

2025-11-11T20:50:24.000Z - 8 months ago

Pulse Biosciences management to meet virtually with Oppenheimer

Nov 6, 2025, 4:05 PM EST - 8 months ago

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Nov 5, 2025, 4:30 PM EST - 8 months ago

Pulse Biosciences Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 8 months ago

Pulse Biosciences Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 8 months ago

Pulse Biosciences Earnings release: Q3 2025

Nov 5, 2025, 4:05 PM EST - 8 months ago

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

Oct 28, 2025, 8:00 AM EDT - 8 months ago

Pulse Biosciences Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 8 months ago

Pulse Biosciences Proxy statement: Proxy Filing

2025-10-24T11:37:00.000Z - 8 months ago

Pulse Biosciences enrolls first patient in NANOCLAMP AF study

Oct 24, 2025, 7:00 AM EDT - 8 months ago

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Oct 22, 2025, 4:05 PM EDT - 8 months ago

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Oct 10, 2025, 7:00 AM EDT - 9 months ago

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Oct 7, 2025, 7:00 AM EDT - 9 months ago

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Sep 10, 2025, 7:00 AM EDT - 10 months ago

Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

2025-09-08T11:05:07.000Z - 10 months ago

Pulse Biosciences granted FDA approval for investigational device exemption

Sep 8, 2025, 7:00 AM EDT - 10 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Sep 3, 2025, 8:00 AM EDT - 10 months ago

Pulse Biosciences Proxy statement: Proxy Filing

Sep 2, 2025, 7:00 AM EDT - 10 months ago

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

Aug 26, 2025, 7:00 AM EDT - 11 months ago

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Aug 18, 2025, 8:00 AM EDT - 11 months ago

Pulse Biosciences Proxy statement: Proxy Filing

Aug 13, 2025, 11:00 AM EDT - 11 months ago

Pulse Biosciences Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Pulse Biosciences Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Pulse Biosciences Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Pulse Biosciences Earnings release: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 11 months ago

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Aug 1, 2025, 7:00 AM EDT - 11 months ago

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Jul 29, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings release: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

May 6, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 1, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Apr 23, 2025, 7:00 AM EDT - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Apr 10, 2025, 9:30 AM EDT - 1 year ago

Pulse Biosciences Transcript: 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Pulse Biosciences Earnings release: Q4 2024

Mar 27, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Mar 26, 2025, 4:05 PM EDT - 1 year ago

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

Mar 7, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

Mar 5, 2025, 10:30 AM EST - 1 year ago

Pulse Biosciences Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 20, 2025, 4:05 PM EST - 1 year ago

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Feb 4, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

prismmarketview Jun. 30 at 3:50 PM

0 · Reply

Carl81 Jun. 29 at 4:17 PM

$PLSE $SMMT You all ready for this ?

0 · Reply

Orbit100 Jun. 29 at 2:34 PM

$PLSE Pulse is the best momentum stock to buy now.

0 · Reply

TruthBroker2 Jun. 29 at 11:56 AM

$PLSE $SMMT .

0 · Reply

TruthBroker2 Jun. 27 at 1:10 AM

$PLSE

0 · Reply

Orbit100 Jun. 26 at 7:52 PM

$PLSE I kept adding today after I bought my shares back. This time I am holding out to see this company to be bought out.

0 · Reply

Orbit100 Jun. 26 at 3:00 PM

$PLSE This time my son told me to hold it out the rest of the year. I know Pulse has the best PFA catheter in the market right now. To some point, the company definitely will be bought out.

0 · Reply

Orbit100 Jun. 26 at 2:58 PM

$PLSE What a gift! Sold $31 and bought back 15000 shares at $28.60.

0 · Reply

Orbit100 Jun. 26 at 2:28 PM

$PLSE Too much, too soon. Sold. This is a stock that I will continue trading in the next 2 years. Good luck to all of the longs.

1 · Reply

TruthBroker2 Jun. 26 at 2:16 PM

$PLSE Whats Really Going on 31

0 · Reply

Carl81 Jun. 26 at 2:08 PM

$PLSE 30 Duck Yeah 👍

0 · Reply

LeisureSuitLarry Jun. 26 at 1:44 PM

$SMMT $PLSE $ABBV

0 · Reply

TruthBroker2 Jun. 26 at 1:38 PM

$PLSE Be Lookin Good👍

0 · Reply

Orbit100 Jun. 25 at 7:51 PM

$PLSE The best PFA catheter in the market. Pulse will get bought.

0 · Reply

TruthBroker2 Jun. 24 at 11:20 AM

$SMMT $PLSE .

0 · Reply

Orbit100 Jun. 22 at 2:03 PM

$PLSE I loaded up 5000 shares of Pulse after studying their PFA catheter and learned not only its accuracy is by far the top notch standard among all other makers, but also the most user friendly. Pulse is a highly potential buyout target by JNJ, Abbott or Medtronic.

1 · Reply

TruthBroker2 Jun. 18 at 11:20 AM

$PLSE $SMMT !!!

0 · Reply

officialshawn Jun. 15 at 1:48 PM

$SMMT Bob posted a video on his instagram about his recent $50,000,000 purchase. He is getting close to a billion invested and I think he will will probably be there soon. $PLSE $ISRG $ABBV

1 · Reply

LeisureSuitLarry Jun. 13 at 8:04 PM

$PLSE

0 · Reply

TruthBroker2 Jun. 13 at 7:45 PM

$PLSE!!!

0 · Reply

BIOTECH_GURU Jun. 12 at 8:09 PM

$PLSE i don't think this is shorting alone. I think this is selling due to forced redemption of warrants resulting in profit taking.

2 · Reply

HoHoHoHum Jun. 12 at 8:05 PM

$PLSE short attack on the back of a planned redemption of warrants, which is not a bad news as such. I added a bunch of shares.

0 · Reply

Market Cap	2.02B
Revenue (ttm)	350,000.00
Net Income (ttm)	-72.78M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-20,794.29%
Debt to Equity Ratio	0.00

Volume	291,400
Avg Vol	359,384
Day's Range	N/A - N/A
Shares Out	69.21M
Stochastic %K	48%
Beta	1.65
Analysts	Strong Sell
Price Target	$30.67